In the landmark SURMOUNT trials, tirzepatide at the 15mg dose produced average body weight reductions of 20.9% over 72 weeks
The inclusion of targeted metabolic and blood sugarsupporting ingredients helps optimize nutrient usage and reduce unwanted cravings
Medical History Your medical history can impact your reaction to shots
The study established the ~6-day half-life, dose-proportional pharmacokinetics, and the 1272 hour Tmax window
This is an impressive result, allowing these drugs to be considered as more than just "weight loss aids." Research into their potential for treating fatty liver disease, alcohol and nicotine addiction, and even Alzheimer's disease is ongoing
Unlike automated weight loss platforms, Eddie founded Peak Performance to bring clinical excellence and personalized care together in one place